Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2011
10/27/2011US20110262438 Biological materials related to cxcr7
10/27/2011US20110262432 mutated netrin 4 proteins, fragments thereof and their uses as drugs
10/27/2011US20110262407 Treatment with alpha7 selective ligands
10/27/2011US20110262396 Combination treatments comprising protease binding proteins for inflammatory disorders
10/27/2011US20110262392 Medium derived from stem cells as a pharmaceutical composition
10/27/2011US20110262388 Novel inhibitors
10/27/2011US20110262386 Methods of treating inflammation
10/27/2011US20110262374 Novel compound ramalin and use thereof
10/27/2011US20110262373 Personalised pharmaceutical composition containing retinoic acid, for anti-aging of the skin
10/27/2011US20110262368 C21 thioethers as glucocorticoid receptor agonists
10/27/2011CA2796592A1 Compounds provided with antioxidant activity against free radicals, and pharmaceutical and cosmetic compositions containing them
10/26/2011EP2380912A1 Novel anti-IGF-IR antibodies and uses thereof
10/26/2011EP2380890A1 New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
10/26/2011EP2380877A1 Pyridine-3-carboxyamide derivative
10/26/2011EP2380872A1 Polycationic compounds and uses thereof
10/26/2011EP2380850A1 Modified sodium-montmorillonite, preparing method and uses thereof
10/26/2011EP2380578A1 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
10/26/2011EP2379548A1 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
10/26/2011EP2379533A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
10/26/2011EP2379484A1 Polyunsaturated fatty acid and diol ester as an anti-acne agent
10/26/2011EP2379082A2 Acne treatment powder foundation
10/26/2011EP2379063A1 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
10/26/2011EP2379062A1 Pharmaceutical composition comprising one or more fumaric acid esters
10/26/2011EP2378876A1 Lower dosage strength imiquimod formulations and short dosing regimens for treating actinic keratosis
10/26/2011EP2378873A1 Method of treating neuropathic pain
10/26/2011EP2378872A1 Acne vulgaris treatment regimen
10/26/2011EP2117499B1 Use of sinapic acid in non-therapeutic cosmetic and/or topical compositions
10/26/2011EP1631293B1 Compounds, formulations, and methods for treating or preventing rosacea
10/26/2011EP1587477B1 Odorless formulation for treating mucosal discontinuities
10/26/2011EP1469310B1 Diagnostic for scleroderma
10/26/2011CN102227427A Cyclobutyl purine derivative, angiogenesis promoting agent, lumenization promoting agent, neurocyte growth promoting agent, and drug
10/26/2011CN102227409A Pyridine-3-carboxyamide derivative
10/26/2011CN102227223A Mineral absorption improver, and method for improving absorption of minerals
10/26/2011CN102227221A Pharmaceutical combination containing hsp90 inhibitor and mtor inhibitor
10/26/2011CN102227220A Hsp90 inhibitors for therapeutic treatment
10/26/2011CN102227208A Drug or dermatological composition containing avocado peptide extract for treating and preventing pruritus
10/26/2011CN102225896A Ether derivatives of rhein and their therapeutic use
10/26/2011CN102225205A Tripterine nano structure lipid carrier and preparation method and application thereof
10/26/2011CN102225201A New application of glycolytic inhibitor
10/26/2011CN102225194A Use of Bv8 and/or EG-VEGF to promote hematopoiesis
10/26/2011CN102225189A Preparation method of baste for eliminating bruise
10/26/2011CN102225178A Fructus galangae extract and medicinal application thereof
10/26/2011CN102225170A Honeysuckle and broom cypress fruit carminative liquid
10/26/2011CN102225156A Plaster for external use for treating dermatophytosis
10/26/2011CN102225143A Medicine for external use for treating psoriasis
10/26/2011CN102225142A Itch relieving ointment for women
10/26/2011CN102225134A Medicament for treating alopecia and preparation method thereof
10/26/2011CN102225124A Plaster for treating leg ecthyma and skin fester
10/26/2011CN102225121A Preparation method of medicament for treating scalding
10/26/2011CN102225118A Blood-activating wind-dispelling liquid
10/26/2011CN102225114A Medicine for treating foot ringworm and preparation method thereof
10/26/2011CN102225113A Traditional Chinese medicine preparation for treating animal dermatosis
10/26/2011CN102225075A Method for preparing beriberi emulsion
10/26/2011CN102225072A Sodium humate skin external preparation for promoting wound healing
10/26/2011CN102225071A Preparation method of external medicine for treating tinea manuum and tinea pedis
10/26/2011CN102225064A Application of isoflavone compound in preparing medicines for treating radiation injuries
10/26/2011CN102225038A Preparation method of hair growth liquid
10/26/2011CN102224975A Soaking liquid medicine for treating tinea manus and pedis and medical healthcare product
10/26/2011CN101912483B Traditional Chinese medicine embrocation of children infantile eczema
10/26/2011CN101874777B Spray containing butenafine hydrochloride
10/26/2011CN101837082B Chinese preparation for treating burn without leaving scar
10/26/2011CN101837016B Chinese medicinal preparation for curing trauma
10/26/2011CN101791344B Traditional Chinese medicine and preparation method thereof
10/26/2011CN101518614B Chinese patent medicine for treating chloasma
10/26/2011CN101513502B Hair growth medicament
10/26/2011CN101337028B Impregnation medicine for treating footpad bromidrosis
10/26/2011CN101337027B Oral traditional Chinese medicine for treating kidney-water depletion type chloasma
10/26/2011CN101306148B Traditional Chinese medicine orally taken for treating intractable psoriasis
10/26/2011CN101306141B Decoction for treating qi-blood disharmony type vitiligo
10/26/2011CN101301442B Decoction for treating papulopustular type acne
10/26/2011CN101301344B Oral Chinese medicine for treating blood-heat drug induced dermatitis
10/26/2011CN101199706B Medicinal oil medicament for treating burn
10/26/2011CN101194975B Powder medicament for treating impetigo
10/26/2011CN101185686B Powder agent medicine for treating eczema
10/26/2011CN101181499B Pharmaceutical combination for curing acne as well as preparations and preparation thereof
10/26/2011CN101048166B Abnormal protein removing composition
10/25/2011US8044207 Pyridinoylpiperidines as 5-HT1F agonists
10/25/2011US8044182 Adiponectin and uses thereof
10/25/2011US8044042 Thienotriazolodiazepine compound and medicinal use thereof
10/25/2011US8044040 e.g. 3-{3-Cyano-6-[(2,2-dimethyl-propyl)-methyl-amino]-5-fluoro-pyridin-2-ylamino}-N-methoxy-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/25/2011US8043855 vector contains an adenoviral genome from which the open reading frames E1 and/or E3 have been deleted, but retains enough sequence to make it able to replicate in vitro; also contains a DNA sequence regulated by promoters that encode for fibrosis treatment proteins
10/25/2011US8043624 Compositions and methods for treatment of microbial infections
10/25/2011CA2505538C Papaya puree and its use
10/25/2011CA2484020C Re-epithelializing pharmaceutical compositions comprising xanthan gum
10/25/2011CA2460834C Matrix metalloproteinase inhibitor
10/20/2011WO2011130342A1 FUSED DERIVATIVES AS ΡI3Κδ INHIBITORS
10/20/2011WO2011130246A2 Compositions with reactive ingredients, and wound dressings, apparatuses, and methods
10/20/2011WO2011129781A1 Diabetic foot processor system
10/20/2011WO2011129588A2 Polymer/liposome nanocomposite composition for percutaneous absorption, and method for preparing same
10/20/2011WO2011129428A1 Cosmetic composition containing plum extract
10/20/2011WO2011129424A1 Pharmaceutical agent for prevention and/or treatment of htlv-1-associated myelopathy
10/20/2011WO2011129399A1 Srebp inhibitor
10/20/2011WO2011128745A2 Fully openable multifunction drawer for household appliances
10/20/2011WO2011127994A1 Active substance complex and formulation comprising it
10/20/2011WO2011127532A1 Tethered matrix metalloproteinase inhibitor
10/20/2011WO2011047173A9 Pharmaceutical compositions for oral administration
10/20/2011US20110258713 Compositions and methods for re-programming cells without genetic modification
10/20/2011US20110257271 Derivatives of dimethylcurcumin
10/20/2011US20110257264 Use of 2,5-dihydroxybenzene derivatives for treating actinic keratosis
10/20/2011US20110257262 Crystalline ingenol mebutate